Position in TXMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,634,742
+$226,517 QoQ
Shares Held
1,192,191
0.0% QoQ
Ownership
10.3%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1
of 45 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TXMD Over Time
Shares Held
Position Value (USD)
Derivatives in TXMD
reported options exposure · as of Jun 30, 2021CallValue
$18,326
CallShares
308
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rubric Capital Management LP holds $1,630,260,569 across 8 Drug Manufacturers - Specialty & Generic names. TXMD ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
34,168,743 | $542,599,638 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
15,575,000 | $527,681,000 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
3,999,800 | $255,787,210 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
10,168,660 | $176,019,504 | |
| 5 | ALVO |
Alvotech
|
15,677,093 | $57,848,473 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
1,279,611 | $46,321,918 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
258,131 | $21,368,084 | |
| 8 | TXMD |
TherapeuticsMD, Inc.
This page
|
1,192,191 | $2,634,742 |
All Filings in TXMD
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,634,742 | 1,192,191 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,408,225 | 1,192,191 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,943,271 | 1,192,191 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,287,566 | 1,192,191 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,382,941 | 1,192,191 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,108,737 | 1,192,191 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,025,284 | 1,192,191 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,979,037 | 1,192,191 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,919,427 | 1,192,191 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,730,117 | 1,192,191 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,682,429 | 1,192,191 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,600,416 | 1,192,191 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $4,911,826 | 1,192,191 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,470,716 | 1,192,191 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,822,697 | 1,757,191 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $7,682,167 | 1,156,953 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,878,718 | 791,831 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,030,834 | 5,344,302 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,923,948 | 5,344,302 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,954,783 | 5,344,302 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $18,326 | 15,400 | Call | Sole | 2021-08-13 | |
| 2021-06-30 | $3,325,219 | 2,794,302 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,744,364 | 2,794,302 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $5,469,938 | 4,520,610 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $22,013,416 | 13,932,542 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,606,592 | 9,285,274 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $10,188,537 | 9,611,828 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||